Literature DB >> 6161177

Human helper T cell factor(s) (ThF). I. Partial purification and characterization.

T Hirano, T Teranishi, H Toba, N Sakaguchi, T Fukukawa, I Tsuyuguchi.   

Abstract

T cells obtained from pleural effusion of patients with tuberculous pleurisy were stimulated in vitro with PPD. The culture supernatant was shown to be substituted for T cells in PWM-induced IgG production by human B cells. As many as 0.5 to 3 x 10(9) lymphocytes were obtained from 1 patient, and about 85% of them were E-rosette positive, making it possible to purify human helper T cell factor(s) (ThF). Helper activity was sensitive to heating at 70 degrees C for 5 min and treatment with trypsin. ThF did not have conventional Ig determinants and was recovered in the 50 to 67% ammonium sulfate fraction. The purification was done by successive DEAE-Sephadex and CM-Sephadex ion-exchange chromatography, Sephadex G-100 gel filtration, and isoelectric focusing. It was shown that ThF activity was eluted by gel filtration in the fraction with a m.w. of about 20,000. Isoelectric focusing of this fraction revealed that ThF activity distributed in the pl range of 6.5 to 8.0, whereas TCGF activity was focused in a single peak at pI of 6.5, indicating the existence of a helper factor without TCGF activity.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6161177

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Antigen-specific and non-specific helper activities derived from supernatants of human influenza virus-specific T-cell lines.

Authors:  E D Zanders; A Fischer; S Smith; P C Beverley; M Feldmann
Journal:  Immunology       Date:  1983-02       Impact factor: 7.397

2.  Interleukin 2 receptors on human B cells. Implications for the role of interleukin 2 in human B cell function.

Authors:  A Muraguchi; J H Kehrl; D L Longo; D J Volkman; K A Smith; A S Fauci
Journal:  J Exp Med       Date:  1985-01-01       Impact factor: 14.307

3.  Three distinct stages of B-cell defects in common varied immunodeficiency.

Authors:  O Saiki; P Ralph; C Cunningham-Rundles; R A Good
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

4.  The defect in peripheral blood B-cell activation in patients with multiple myeloma is not due to a deficiency in the production of B-cell growth and differentiation factors.

Authors:  T Commes; B Klein; M Jourdan; G Clofent; F Houssiau; J Grenier; R Bataille
Journal:  J Clin Immunol       Date:  1989-01       Impact factor: 8.317

Review 5.  Interleukin 6 in autoimmune and inflammatory diseases: a personal memoir.

Authors:  Toshio Hirano
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2010       Impact factor: 3.493

Review 6.  Revisiting the 1986 molecular cloning of interleukin 6.

Authors:  Toshio Hirano
Journal:  Front Immunol       Date:  2014-09-23       Impact factor: 7.561

7.  Early Secreted Antigenic Target of 6-kDa of Mycobacterium tuberculosis Stimulates IL-6 Production by Macrophages through Activation of STAT3.

Authors:  Bock-Gie Jung; Xisheng Wang; Na Yi; Justin Ma; Joanne Turner; Buka Samten
Journal:  Sci Rep       Date:  2017-01-20       Impact factor: 4.379

Review 8.  IL-6 in inflammation, autoimmunity and cancer.

Authors:  Toshio Hirano
Journal:  Int Immunol       Date:  2021-03-01       Impact factor: 4.823

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.